Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
Quick Stats
Jan 30, 202660.8
AI Score
BUY1.38
Volume Ratio
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
MAZE Stock Summary
Last updated Jan 30, 2026
MAZE is currently trading at $43.58, positioned above its 200-day moving average of $23.39, indicating a long-term uptrend. The stock has a 52-week range of $6.71 to $47.36.
Technical Analysis: The 50-day moving average stands at $40.42, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 54.713, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.154, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates MAZE at 60.8/100 with a BUY recommendation.
MAZE (Maze Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 54.713 |
| CMF (20) | 0.154 |
| ROC (10) | 9.47 |
| ADX (14) | 21.756 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.384 |
| AROONOSC (14) | 42.857 |
| WILLAMS %R (14) | -40.385 |
| MFI (14) | 53.773 |
MAZE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MAZE Price vs Max Options Open Interest
MAZE Max Change In Options Open Interest
MAZE Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MAZE Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MAZE Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MAZE Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Maze Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
MAZE Moving Averages Analysis
Maze Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Maze Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
MAZE (Maze Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 44.22 |
| 20 | 42.06 |
| 30 | 41.74 |
| 50 | 40.42 |
| 100 | 34.16 |
| 200 | 23.39 |
MAZE Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.2 billion |
| Earnings/Share ($) | -2.56 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.0696 |
| EPS Estimate Next Year ($) | -3.146 |
| WallStreet Target Price ($) | 49.4444 |
| Most Recent Quarter |